PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Omega-3-Acid Ethyl Esters→

Omega 3 Acid Ethyl Esters PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
308081-97-2
Molecular formula
Not available
Molecular weight
Not available
Drug class
Omega-3 fatty-acid lipid-modifying agentantihypertriglyceridaemic
Mechanism of action
The complete mechanism is not fully understood. Proposed actions include reduced hepatic triglyceride synthesis, increased hepatic fatty-acid oxidation and increased plasma lipoprotein-lipase activity.
Indications / reported uses
  • Adjunct to diet to reduce triglyceride concentrations in adults with severe hypertriglyceridaemia, as specified by the product label.

Sources: https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9499c40e-6665-4fbf-914d-1a9931b93562 · https://www.dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=787f9929-ef31-42a7-a305-8ba343e39672&type=display

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Omega 3 Acid Ethyl Esters PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Omega 3 Acid Ethyl Esters Permitted Daily Exposure (PDE) report (the Omega 3 Acid Ethyl Esters PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Omega 3 Acid Ethyl Esters Occupational Exposure Limit (OEL) report (the Omega 3 Acid Ethyl Esters OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.